Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival Evidence from four decades of US population data》.pdf

Cancer Epidemiology 39 (2015) 720–726 Contents lists available at ScienceDirect Cancer Epidemiology The International Journal of Cancer Epidemiology, Detection, and Prevention journal homepage: www.cancerepidemiology .net Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: Evidence from four decades of US population data a,b,* a c Md Jobayer Hossain , Li Xie , Emi H. Caywood a Nemours Biomedical Research, A I duPont Hospital for Children, Wilmington, DE 19803, United States b Department of Applied Economics and Statistics, University of Delaware, Newark, DE 19716, United States c Department of Hematology/Oncology, A I duPont Hospital for Children, Wilmington, DE 19803, United States A R T I C L E I N F O A B S T R A C T Article history: Growing insight into prognosis of pediatric acute myeloid leukemia (AML) survival has led to improved Received 8 January 2015 outcome over time and could be further enhanced through investigation using a large number of Received in revised form 8 June 2015 patients. To characterize the extent of the association of pediatric AML survival with its identified Accepted 28 June 2015 prognostic factors, we analyzed the United States population-based Surveillance Epidemiology and End Available online 6 July 2015 Results (SEER) large dataset of 3442 pediatr